-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The market share of imported brands in China's DR equipment market fell from 46% in 2014 to 23% in 2016
the domestic high-end medical device market has long been monopolized by GPS. The so-called "GPS" is short for three multinationals in the medical equipment industry: General Electric, Philips and Siemens. The price of medical equipment in these enterprises is very high, on average two or three times, or even higher, for domestic equipment. Industry insiders say: domestic large-scale medical equipment enterprises have been unable to compete with foreign brands for four reasons: First, the product line is not rich, some varieties only one or two products; Since 'GPS' is an absolute monopoly in the global market for high-end medical devices, it also has absolute control over pricing. The same DR, which sells for $80,000 in the US, is worth Rmb2m in the Chinese market. However, with the rise of domestic medical device manufacturers such as United Shadow, Meirui, Anjian and Wandong, the "GPS" monopoly pattern is facing great pressure. From 2014 to 2016, the market share of imported brands in China's DR equipment market fell from 46% in 2014 to 23% in 2016, according to an authoritative agency. With the rise of domestic brands, the market share of imported brands will continue to shrink.brand DR equipment has become the main force in winning the bid
with the government's continuous emphasis on primary health care and the continuous promotion of medical reform, China's DR equipment procurement will also usher in a period of rapid growth. With excellent product quality and reasonable product prices, domestic brand DR products have become the main product of government procurement. Based on an analysis of sales records for DR equipment purchases from January 1, 2017 to September 13, 2017, 66 of the 170 winning announcements did not disclose the brand and model of the winning DR equipment. Of the 104 winning announcements that revealed the brand and model of DR equipment, 63 items purchased domestic brand DR products and only 41 items purchased imported brand products.
in terms of brand distribution, Shenzhen Anjian Technology Co., Ltd. and China Resources Wandong Medical Equipment Co., Ltd. are located in the top two in the number of winning projects. The four foreign brands, Siemens, Philips, GE and Isazu, are in the 3-6th place in the list of winning projects. (Pharmaceutical Network)